A trial for coronavirus vaccine researchers: Making sure black and Hispanic communities are included in studies
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Former Centers for Disease Control and Prevention Director Tom Frieden on Sunday said the U.S. had been a “laggard” in addressing the coronavirus pandemic, specifically pointing to lack of centralized information.
Submitted by mike kraft on
Submitted by mike kraft on
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31594-4/fulltext?dgcid=raven_jbs_etoc_email#%20
Submitted by mike kraft on
On June 26, a small South San Francisco company called Vaxart made a surprise announcement: A coronavirus vaccine it was working on had been selected by the U.S. government to be part of Operation Warp Speed, the flagship federal initiative to quickly develop drugs to combat Covid-19.
Vaxart’s shares soared. Company insiders, who weeks earlier had received stock options worth a few million dollars, saw the value of those awards increase sixfold. And a hedge fund that partly controlled the company walked away with more than $200 million in instant profits.
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on